A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

Thanks to Whatgeek for sponsoring this Short. Get our full database of all the keyboards we've reviewed. Brands! Work with us ...

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials ...

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

An Isle of Wight drug driver was caught by police after a database check found her vehicle was overdue on insurance and tax.

FDA delayed fast-track reviews for multiple drugs after safety and efficacy concerns, including adverse events and a reported ...

A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.